EQUITY of EVIL’s Brave New World

by Rudy Mazzocchi

Posted on 2012-05-24

One of the very first novels I ever read “cover to cover” was Aldous Huxley’s Brave New World. I am still amazed that this was first published back in 1932. One of the key elements of this novel was that it anticipated developments in reproductive technology. So here we are in 2012, still struggling with the legal and moral aspects of abortion while trying to figure out how to jump the ethical gap on other topics such as embryonic stem cells.

Huxley’s story takes place in AD 2540, but I believe that the eve of our brave new world is already upon us. The global headlines are filled with stories of human trafficking, the illegal sale of human organs, the sales trade of sperm and eggs, the commercialization of embryonic stem cells, and even the clandestine activities surrounding human cloning. So we close our eyes and ears and refuse to admit that these billion dollar industries already exist, dispite dozens of laws passed over the prior two decades, designed to punish those who dare to “play god”.

EQUITY of EVIL was designed to tell a similar story, to enlighten the reader, to pursuade people to start thinking about the reality of our brave new world. The story holds no answers or suggests any resolution, but it reveals how business, greed, and the deceit of man can play a role in the exploitation of human life.

EQUITY of EVIL – Book Trailer

Thanks for listening…

www.rudymazzocchi.com

← Go Back

Recent Posts

Discover even more from the writer's mind

Click here to visit our blog

EQUITY SERIES - Rudy A. Mazzocchi

Rudy A. Mazzocchi

Rudy Mazzocchi is best known as a medical device and biotechnology entrepreneur, inventor, and angel investor, with a history of starting new technology ventures throughout the U.S. and Europe. He's been privileged to have the opportunity to see the newest innovations in healthcare and work with some of the most brilliant researchers, scientists, and physicians in the industry.

Authoring more than 90 patents, he has helped pioneer new companies involved in cardiology, oncology, orthopedics, neurosurgery and even embryonic stem-cell development. Through these efforts, he has become the recipient of many technologies and business awards, including the Ernst & Young Entrepreneur of the Year in Healthcare and the Businessman of the Year Award.

Combining these experiences and opportunities, with thousands of hours of travel and long evenings in hotel rooms, he found the initiative to start writing a collection of medical thrillers based on true events, the first of which is entitled Equity of Evil.